SYRS

Syros Pharmaceuticals Inc
UnclassifiedUSCUSIP 87184Q206◍ Confluence graph
Tracked 13F Holders
0
-3 QoQ
13F Value (tracked)
$0
Insider Net · 180d
$0
0↑ 0↓
Recent Filings
15
Smart-money sentimentMixed
BearishBullish
13F funds (latest Q)0 adding · 0 trimming
Insider net (180d)$0
Price-derived chart withheld or not yet available for SYRS.
Build

Use SYRS data in an agent

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Build

Ask your agent who owns SYRS

This stock page is the Follow view. The Build view lets your agent query SYRS owners, fund changes, insider filings, and source links through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/SYRS"
Ask your agent
Use Arkolith to show who owns SYRS,
which funds added or reduced it, and which
SEC filings prove each claim.

Top institutional holders

0 tracked 13F filers

Not held in any tracked 13F filing yet.

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$0
0 insiders
Sells · 180d
$0
0 insiders
Net
$0
0 P/S txns
Signal
Mixed
open-market
DateInsiderRoleActionSharesValue
Dec 2, 2024Simonian Nancy ADirectorSell (S)37K$10K
Nov 25, 2024Simonian Nancy ADirectorSell (S)135K$36K
Nov 19, 2024Quirk Gerald EChief Legal & Compliance OfficSell (S)47K$10K
Nov 18, 2024Haas JasonChief Financial OfficerSell (S)138K$29K
Nov 18, 2024Chee ConleyPresident & CEO, DirectorSell (S)135K$27K
Nov 18, 2024Roth DavidChief Medical OfficerSell (S)12K$2K
Nov 18, 2024Stephens KristinChief Development OfficerSell (S)36K$8K
Oct 31, 2024Stephens KristinChief Development OfficerTax withholding (F)6K$13K
Oct 31, 2024Stephens KristinChief Development OfficerOption exercise (M)17K
Oct 31, 2024Stephens KristinChief Development OfficerOption exercise (M)17K$0
Oct 31, 2024Chee ConleyPresident & CEO, DirectorOption exercise (M)17K
Oct 31, 2024Chee ConleyPresident & CEO, DirectorTax withholding (F)9K$18K

Institutional ownership over time

0 funds-53 since Q1 2024
02753Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025
funds holding aggregate valuelatest $0

Funds that own SYRS also own

CompanyCo-held byCombined value
UNITEDHEALTH GROUP INCUNH33 funds$45.4B
ELI LILLY & COLLY33 funds$42.0B
JOHNSON & JOHNSONJNJ33 funds$35.8B
ABBVIE INCABBV33 funds$33.4B
MERCK & CO. INC.MRK33 funds$25.1B
THERMO FISHER SCIENTIFIC INCTMO33 funds$24.4B
PFIZER INCPFE33 funds$19.1B
CVS HEALTH CORPCVS33 funds$12.7B
MEDTRONIC PLCMDT33 funds$11.6B
REGENERON PHARMACEUTICALSREGN33 funds$10.1B
GILEAD SCIENCES INCGILD33 funds$9.9B
ELEVANCE HEALTH INCELV33 funds$8.7B

Ranked by how many of SYRS's institutional holders also hold each name, a cross-fund conviction signal. Via the MCP server (ticker.co_held).

Recent filings

15 shown

Browse more

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for SYRS. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.